Innovations in Pulmonary Arterial Hypertension Treatment (2024–2034)
Market Overview The Pulmonary Arterial Hypertension (PAH) market is gaining substantial attention globally due to the growing prevalence of cardiovascular and pulmonary disorders. PAH is a progressive condition characterized by high blood pressure in the arteries of the lungs, leading to heart failure if untreated. As awareness and diagnostic accuracy improve, more patients are...
0 Comments 0 Shares 7 Views 0 Reviews
Sponsored